NASDAQ: CPBCampbell's Co Stock
$35.52+0.56 (+1.6%)
Updated May 16, 2025
CPB Price
$35.52
Fair Value Price
N/A
Market Cap
$10.59B
52 Week Low
$34.27
52 Week High
$52.81
P/E
20.3x
P/B
2.71x
P/S
1.15x
PEG
0.88x
Dividend Yield
3.18%
Revenue
$10.12B
Earnings
$521.00M
Gross Margin
30.6%
Operating Margin
10.24%
Profit Margin
5.1%
Debt to Equity
3.07
Operating Cash Flow
$1B
Beta
0.18
Next Earnings
N/A
Ex-Dividend
Jul 3, 2025
Next Dividend
Aug 4, 2025
CPB Overview
Campbell Soup Company manufactures soup and other convenience food products. The firm's well-known brands are Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. The company was founded in 1869 and is headquartered in Camden, NJ.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CPB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
C
CPB
Ranked#24 of 50
Ranked#24 of 50
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.87 | A | |
| $13.39 | A | |
| $140.81 | A |
Be the first to know about important CPB news, forecast changes, insider trades & much more!
CPB News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CPB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CPB ($35.52) is trading above its intrinsic value of $23.31, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CPB is good value based on its earnings relative to its share price (20.3x), compared to the US market average (25.95x)
P/E vs Market Valuation
CPB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CPB due diligence checks available for Premium users.
Valuation
CPB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
20.3x
Industry
19.88x
Market
25.95x
CPB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CPB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CPB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.71x
Industry
1.91x
CPB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CPB price to earnings growth (PEG)
For valuing profitable companies with growth potential
CPB is good value based... subscribe to Premium to read more.
PEG Value Valuation
CPB's financial health
Profit margin
Revenue
$2.7B
Net Income
$173.0M
Profit Margin
6.4%
CPB's Earnings (EBIT) of $1.04B... subscribe to Premium to read more.
Interest Coverage Financials
CPB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$15.9B
Liabilities
$12.0B
Debt to equity
3.07
CPB's short-term liabilities ($3.41B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CPB's long-term liabilities ($8.59B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CPB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CPB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$512.0M
Investing
-$128.0M
Financing
-$363.0M
CPB's operating cash flow ($1.24B)... subscribe to Premium to read more.
Debt Coverage Financials
CPB vs Food Stocks
Campbell's Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.